John H. Joseph, MD

Director
Clinical Testing of Beverly Hills

Disclosure information not submitted.

Presentation(s):

• The results of a Computational model-informed comparative evaluation of Botulinum Toxin formulations. Does this model demonstrate the reason for the variable potency between "Units" of commercially available Toxins?

  Friday, May 15, 2026
  9:30 AM - 9:40 AM CT

• Panel Discussion – Injectables in 2026

  Friday, May 15, 2026
  9:40 AM - 9:50 AM CT

• If accessory proteins dissociate, why don't toxins behave the same? multiscale simulation shows divergent in silico profiles despite an identical core neurotoxin

  Saturday, May 16, 2026
  5:20 PM - 5:25 PM CT

• Panel Discussion Hot Topics 2

  Saturday, May 16, 2026
  5:55 PM - 6:00 PM CT